Slender Sheath/Guiding Catheter Combination vs. Sheathless Guiding Catheter for Acute Coronary Syndrome: A Propensity-Matched Analysis of the Two Devices
Table 6
Thirty-day clinical outcomes by Cox proportional hazard ratio model analysis.
Variables
Cumulative events at 30 days (%)
Hazard ratio (95% CI)
Glidesheath
Sheathless
Total population
All-cause death
4 (1.1)
1 (0.2)
7.30 (1.08–142.74)
0.075
Myocardial infarction
0 (0)
2 (0.3)
0.83 (0.04–8.67)
0.88
Stent thrombosis
4 (1.0)
1 (0.1)
8.94 (1.44–171.24)
0.046
TLR
0 (0)
1 (0.1)
1.68 (0.07–42.61)
0.71
Stroke
2 (0.5)
1 (0.1)
5.12 (0.65–103.56)
0.16
Propensity-matched population
All-cause death
4 (1.2)
1 (0.3)
4.06 (0.60–79.31)
0.21
Myocardial infarction
0 (0)
1 (0.3)
0.87 (0.03–22.09)
0.92
Stent thrombosis
3 (0.8)
1 (0.3)
3.98 (0.59–77.80)
0.22
TLR
0 (0)
1 (0.3)
0.99 (0.86–1.15)
0.96
Stroke
2 (0.6)
0 (0)
n/a
n/a
“Glidesheath” denotes the 7-Fr Glidesheath slender/7-Fr guiding catheter combination group and “Sheathless” denotes the 7.5-Fr sheathless guiding catheter group. The asterisk denotes a statistically significant difference between the two groups. CI, confidence interval; n/a, not applicable; TLR, target-lesion revascularization.
